Zhejiang Anglikang Pharmaceutical Co. Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 20.69% vs -20.25% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 198.31% vs -231.11% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "330.80",
          "val2": "274.10",
          "chgp": "20.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22.40",
          "val2": "-12.50",
          "chgp": "279.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.30",
          "val2": "3.60",
          "chgp": "-8.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "17.40",
          "val2": "-17.70",
          "chgp": "198.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "67.80%",
          "val2": "-123.30%",
          "chgp": "19.11%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -5.30% vs 3.56% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -17.04% vs 38.71% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,523.40",
          "val2": "1,608.60",
          "chgp": "-5.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "204.10",
          "val2": "242.20",
          "chgp": "-15.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "17.10",
          "val2": "14.70",
          "chgp": "16.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.80",
          "val2": "-0.80",
          "chgp": "-125.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "151.90",
          "val2": "183.10",
          "chgp": "-17.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "75.90%",
          "val2": "100.50%",
          "chgp": "-2.46%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

330.80

274.10

20.69%

Operating Profit (PBDIT) excl Other Income

22.40

-12.50

279.20%

Interest

3.30

3.60

-8.33%

Exceptional Items

0.00

0.00

Consolidate Net Profit

17.40

-17.70

198.31%

Operating Profit Margin (Excl OI)

67.80%

-123.30%

19.11%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 20.69% vs -20.25% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 198.31% vs -231.11% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,523.40

1,608.60

-5.30%

Operating Profit (PBDIT) excl Other Income

204.10

242.20

-15.73%

Interest

17.10

14.70

16.33%

Exceptional Items

-1.80

-0.80

-125.00%

Consolidate Net Profit

151.90

183.10

-17.04%

Operating Profit Margin (Excl OI)

75.90%

100.50%

-2.46%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -5.30% vs 3.56% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -17.04% vs 38.71% in Dec 2023

All Annual Results